Skip to main content

Promacta News

American Society of Hematology, Dec. 7 to 10

The annual meeting of the American Society of Hematology was held from Dec. 7 to 10 in San Diego and attracted participants from around the world, including hematology specialists as well as clinical ...

FDA Medwatch Alert: Novartis Issues Voluntary Nationwide Recall of Promacta 12.5 mg for Oral Suspension Due to Potential Peanut Contamination

May 11, 2019 – Novartis today announced a voluntary recall of three lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level. The oral suspension lots are being recalled...

FDA Approves Promacta (eltrombopag) for First-Line Severe Aplastic Anemia

Basel, November 16, 2018 - Novartis announced today that the US Food and Drug Administration (FDA) has expanded the label for Promacta (eltrombopag) to include first-line treatment for adults and...

FDA Extends Use of Promacta (eltrombopag) in Pediatric Patients with Immune Thrombocytopenic Purpura

August 24, 2015 – The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood dis...

FDA Approves Promacta for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication

SAN DIEGO, June 12, 2015 --(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that the FDA has approved a supplemental New Drug Application (sNDA) for the use of Promacta...

FDA Approves New Indication for Promacta (eltrombopag) for Severe Aplastic Anemia

London, UK – 26 August 2014 – GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the...

FDA Approves New Indication for Promacta (eltrombopag)

LONDON, Nov. 19, 2012 – GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Promacta for the treatment of thrombocytopenia (low blood platelet counts)...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Idiopathic (Immune) Thrombocytopenic Purpura

Promacta patient information at Drugs.com